Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Organovo Holdings Inc is a biotechnology business based in the US. Organovo shares (ONVO) are listed on the NASDAQ and all prices are listed in US Dollars. Organovo employs 11 staff and has a market cap (total outstanding shares value) of 0.00.
Our top pick for
Long-term investors
Our top pick for
Beginners
Our top pick for
Active traders
| Latest market close | $2.90 |
|---|---|
| 52-week range | $3.56 - $23.92 |
| 50-day moving average | $4.55 |
| 200-day moving average | $6.93 |
| Wall St. target price | $3.00 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-1.40 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $2.9 from 2022-01-20
| 1 week (2022-01-14) | -22.46% |
|---|---|
| 1 month (2021-12-22) | -27.68% |
| 3 months (2021-10-22) | -52.69% |
| 6 months (2021-07-22) | -62.72% |
| 1 year (2021-01-22) | -79.68% |
|---|---|
| 2 years (2020-01-22) | 698.46% |
| 3 years (2019-01-22) | 194.57% |
| 5 years (2017-01-20) | 3.51 |
| Gross profit TTM | $-1,103,000 |
|---|---|
| Return on assets TTM | -18.46% |
| Return on equity TTM | -41.13% |
| Profit margin | 0% |
| Book value | $3.93 |
| Market capitalisation | $32.6 million |
TTM: trailing 12 months
We're not expecting Organovo to pay a dividend over the next 12 months.
Organovo's shares were split on a 1:20 basis on 18 August 2020. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Organovo shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Organovo shares which in turn could have impacted Organovo's share price.
Over the last 12 months, Organovo's shares have ranged in value from as little as $3.56 up to $23.92. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Organovo's is 0.481. This would suggest that Organovo's shares are less volatile than average (for this exchange).
Organovo Holdings, Inc. , a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive human liver tissue and ExVive human kidney tissue used for predictive preclinical testing of drug compounds. It is also developing in vivo liver tissues to treat end-stage liver, life-threatening, and orphan diseases. The company was incorporated in 2007 and is headquartered in Solana Beach, California. .
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Read our expert analysis on Vigorus and how the token will perform in the future.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Donut earns up to 10% APY, but you must have an iOS device.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.